300 related articles for article (PubMed ID: 31333461)
1. New Lipid Mediators in Retinal Angiogenesis and Retinopathy.
Fleming I
Front Pharmacol; 2019; 10():739. PubMed ID: 31333461
[TBL] [Abstract][Full Text] [Related]
2. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
Frömel T; Hu J; Fleming I
Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
[TBL] [Abstract][Full Text] [Related]
3. Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.
Dos Santos LRB; Fleming I
Prostaglandins Other Lipid Mediat; 2020 Jun; 148():106407. PubMed ID: 31899373
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report.
Shao Z; Fu Z; Stahl A; Joyal JS; Hatton C; Juan A; Hurst C; Evans L; Cui Z; Pei D; Gong Y; Xu D; Tian K; Bogardus H; Edin ML; Lih F; Sapieha P; Chen J; Panigrahy D; Hellstrom A; Zeldin DC; Smith LE
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):581-6. PubMed ID: 24458713
[TBL] [Abstract][Full Text] [Related]
5. Müller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid.
Hu J; Popp R; Frömel T; Ehling M; Awwad K; Adams RH; Hammes HP; Fleming I
J Exp Med; 2014 Feb; 211(2):281-95. PubMed ID: 24446488
[TBL] [Abstract][Full Text] [Related]
6. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
[TBL] [Abstract][Full Text] [Related]
8. Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis.
Frömel T; Fleming I
Antioxid Redox Signal; 2015 May; 22(14):1273-92. PubMed ID: 25330284
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and vascular stability in eicosanoids and cancer.
Hu J; Frömel T; Fleming I
Cancer Metastasis Rev; 2018 Sep; 37(2-3):425-438. PubMed ID: 29808461
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-derived fatty acid epoxides and diols in angiogenesis and stem cell biology.
Frömel T; Naeem Z; Pirzeh L; Fleming I
Pharmacol Ther; 2022 Jun; 234():108049. PubMed ID: 34848204
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity.
Hu J; Bibli SI; Wittig J; Zukunft S; Lin J; Hammes HP; Popp R; Fleming I
J Clin Invest; 2019 Dec; 129(12):5204-5218. PubMed ID: 31479425
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy.
Hu J; Dziumbla S; Lin J; Bibli SI; Zukunft S; de Mos J; Awwad K; Frömel T; Jungmann A; Devraj K; Cheng Z; Wang L; Fauser S; Eberhart CG; Sodhi A; Hammock BD; Liebner S; Müller OJ; Glaubitz C; Hammes HP; Popp R; Fleming I
Nature; 2017 Dec; 552(7684):248-252. PubMed ID: 29211719
[TBL] [Abstract][Full Text] [Related]
13. Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.
Jones RD; Liao J; Tong X; Xu D; Sun L; Li H; Yang GY
Front Pharmacol; 2019; 10():731. PubMed ID: 31293429
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase: A potential target for metabolic diseases.
He J; Wang C; Zhu Y; Ai D
J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325
[TBL] [Abstract][Full Text] [Related]
15. The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease.
Fleming I
Pharmacol Rev; 2014 Oct; 66(4):1106-40. PubMed ID: 25244930
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
17. Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future.
Park B; Corson TW
Front Pharmacol; 2019; 10():95. PubMed ID: 30792659
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis.
McReynolds CB; Hwang SH; Yang J; Wan D; Wagner K; Morisseau C; Li D; Schmidt WK; Hammock BD
Front Pharmacol; 2019; 10():533. PubMed ID: 31214021
[TBL] [Abstract][Full Text] [Related]
19. The cytochrome P450 pathway in angiogenesis and endothelial cell biology.
Fleming I
Cancer Metastasis Rev; 2011 Dec; 30(3-4):541-55. PubMed ID: 22009065
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450-dependent eicosanoid production and crosstalk.
Fleming I
Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
